The Process – how does it work?
Step one: Register your interest
You can register online here or contact us by phone or email. If you register online then we will take some basic information to assess your suitability, or our call centre agent will ask you some initial questions and provide you with information on upcoming clinical studies. These questions will include but is not limited to:
If you are suitable for a study and would like to take part in an initial clinical study screening, then you will be invited to a screening appointment at our unit in London Bridge, UK.
Step two: Initial screening appointment at our research centre
Candidates that appear suitable from the basic information taken will have a free medical check-up to assess physical health and suitability for taking part in the research. At this screening we will provide you with specific documents detailing all of the information about the clinical study that you have registered for, including previous clinical investigations that have been conducted and data from these – you can then make an informed decision on whether or not you wish to take part. The screening will be overseen by a physician who will be able to answer any specific questions you have about the research study that you have registered for.
The medical check up will be performed by our nursing team, this check will include, but is not limited to:
Volunteers that pass the screening will be contacted by the volunteer recruitment team who will let you know your results and tell you the admission date and time of the clinical study.
Step three: taking part in the clinical study
Candidates that have successfully made it past the screening will progress on to the scientifically controlled study.
Each clinical study that is conducted in the UK must be approved by independent governmentally authorised ethics committees and must be in accordance with EU legislation. The safety of volunteers is the most important aspect of every study and so all studies are also approved by the Medicines and Healthcare products Regulatory Authority (MHRA).
Clinical studies are an incredibly important part of the process of getting new drugs and treatments onto the market, as such they are stringently designed to guarantee the quality, reliability, and safety of new medicines.
Quintiles Drug Research Unit at Guy’s Hospital has conducted over 1000 Phase I development clinical studies worldwide in the last seven years.
These studies have used thousands of paid volunteers taking part in them, and each one makes a hugely valuable contribution to medical research.